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Abstract: 
Zinc is an essential mineral playing a pivotal role in numerous aspects of cellular metabolism. Zinc deficiency 
affects all age groups, but the effect on growing children is very severe. Zinc deficiency is known to cause 
stunted growth and development in children. However, there are no reliable biomarkers of zinc status to assess 
health risk. Without a specific, sensitive biomarker to determine the zinc nutritional status, zinc intervention 
program is a struggle. Sensitive and specific analysis of zinc status is hence cardinal to defining optimal zinc 
status and setting evidence-based reference intake level. Given the lack of an accurate, sensitive zinc biomarker 
that reflects zinc nutrition across various populations and situations, research is needed to identify new 
biomarkers. Presently, the biochemical marker for measuring the zinc status is analyzing the plasma zinc. 
However, zinc homeostasis depends on many factors complicating the detection of marginal zinc deficiency. 
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INTRODUCTION: 
Global estimates suggest that maternal and child 
undernutrition is responsible for causing diseases in 
children below five years at a rate of about 35% and 
deaths of 3.5 million per year. This is due to the 
deficiency of vitamin and nutrients. The ability to 
assess the role of nutrition in disease prevention and 
health promotion is predicted on the possibility of 
identifying precise and well-founded biomarkers that 
reflect nutrient exposure, status, and effect. 156 
million children under age of 5 around the world are 
stunted [1]. Stunting and other forms of under 
nutrition are a major contributing factor to child 
mortality, disease and disability. Micronutrient 
deficiencies including deficiencies of vitamin A, 
iodine, zinc and folic acid are common factors 
contributing to the stunted children. 
 
Zinc deficiency 
Zinc deficiency is due to inadequate intake or mal-
absorption of zinc from diet. People having the diet of 
plant products are limited with zinc availability and 
absorption due to high levels of inhibitors like fibre 
and phytates, compared to populations having animal 
products. It is estimated that zinc deficiency affects 
about one third of world’s population according to 
food availability data, although severe zinc deficiency 
is rare, mild-to-moderate zinc deficiency is quite 
common around the world. The WHO and UNICEF 
recognise zinc deficiency as being one of the most 
important health issues globally. Zinc act as a 
regulatory ion, a catalyst or a structural element thus 
playing an important role [2]. Zinc deficiency affects 
half of the global population. Worldwide, zinc 
deficiency is responsible for approximately 16% of 
lower respiratory tract infections, 18% of malaria and 
10% of diarrhoeal disease [3]. High mortality among 
children resulting from these infections has been 
reported due to zinc deficiency [4]. Prevalence of zinc 
deficiency is very common, and 61% of the 
population is at the increased risk of low dietary 
intake. Undernutrition has taken a heavy toll in 
developing countries like India, as 47% of children 
are enduring malnutrition and also India is one of the 
foremost countries with hunger situation. Zinc is vital 
to protein synthesis, cellular growth, and cellular 
differentiation. Zinc is a cofactor for the functioning 
of ~ 300 different proteins. The zinc status is varied 
during infection and inflammation. Studies in children 
have corroborated the important role of zinc in the 
modulation of immune function, growth, and 
development. Mild to moderate zinc scantiness makes 
them vulnerable to infection. Zinc or zinc-dependent 
proteins therefore directly affect the transcription and 
translation, thus regulating the expression of proteins 
and other metabolites [5]. 
Zinc is an indispensable metal vital for balanced 
growth and development. Zinc is the second most 
copious metal after iron in the human body. Zinc is a 
paramount cofactor for over more than 300 enzymes 
[5]. Around 3% of human genome encompassing 709 
genes code for zinc bearing transcription factors [25]. 
Zinc is vital for insulin metabolism and signaling 
[6,7]. Zinc plays a crucial role in multitudinous 
biochemical and physiological pathways involving 
gene expression, signal transduction and antioxidant 
defense [8-10]. Inadequate consumption of zinc is a 
worldwide problem notably affecting India.  About 
2.1 million deaths among Indian children (<5 years) 
occur due to typhoid, malaria, measles and 
pneumonia. Evidently 1000 children die from diarrhea 
alone every day. All these are attributed to reduced 
zinc consumption. In five Indian states, current 
epidemiological research has revealed high 
extensiveness of zinc deficiency among children 
associated with low socioeconomic groups outlining 
an overall zinc deficiency of 43.8% (cut-off level (≤ 
65 µg/dL) based on serum zinc levels. Orissa was the 
highest with (51.3%) followed by Uttar Pradesh 
(48.1%), Gujarat (44.2%), Madhya Pradesh (38.9%), 
and Karnataka (36.2%) [11,12]. One more recent 
cross-sectional study (n=630) confirmed low plasma 
zinc concentrations and substandard cognitive 
performance in 45% of adolescent girls in India, 
signifying the need to adopt dietary zinc for normal 
health (12). Nearly (64.6%) of pregnant women have 
been shown to suffer zinc deficiency in the state of 
Haryana, because of low intake of dietary zinc [13]. 
Zinc deficiency causes a metabolic and clinical 
deficiency that has no symptoms leading to imperfect 
growth, wasting and stunting. Correlation of zinc 
depletion to zinc status physiologically is due to an 
incomplete understanding of biological functions of 
zinc.  
 
Markers for Zinc status 
There are several reported methods of identifying zinc 
deficiency, and each method has its advantages and 
disadvantages.  According to BOND zinc expert 
panel, serum or plasma zinc concentration values act 
as a biomarker for dietary zinc consumption and 
stunting acts as a functional indicator of zinc status 
[14]. Plasma zinc concentration levels have been 
proposed as a reliable marker to measure zinc status 
as they react positively to acute dietary zinc restriction 
or zinc addition stimulus. Zinc status can be measured 
in people at the peril of zinc insufficiency by 
estimating the plasma zinc concentration. Plasma zinc 
status cannot be considered as gold standard as they 
have their own constraints. Foods rich in zinc and 
foods which are added with zinc respond differently 
when their plasma levels are quantified, and they are 
also affected by the physiological condition of the 
person. At the same time, not enough information is 
available about whether blood cells, urine, nails, and 
hairs can be used as a source of zinc to predict zinc 
levels [14].  Bui (2013) [15] reported zinc intake was 
inconsistently associated with markers of serum zinc 
concentration. The associations between zinc intake 
was assessed with serum zinc, alkaline phosphatise 
and serum albumin as the biomarkers.  Lowe [16] has 
elaborately reviewed on 32 potential biomarkers from 
46 publications. Using plasma zinc concentration as a 
biomarker is reliable during an effective response to 
zinc to intervention such as growth in children or 
immune response. Modulation of plasma zinc 
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concentration occurs in response to zinc intake or 
depletion. But using plasma zinc as biomarkers has 
several pitfalls. The factors affecting zinc status are 
bioavailability, physiological state of the person, the 
possibility of zinc being metabolized when consumed 
as food or a supplement and analytical considerations 
such as contamination of plasma by hemolysis of 
blood and equipment used to collect blood. Measuring 
hair zinc concentration has several drawbacks as the 
level measured does not reflect the current zinc 
concentration. Because zinc is incorporated in the hair 
follicle during growth and as the hair matures it 
undergoes keratinization resulting in trapping of zinc 
in the protein structure of hair. Hence, the amount of 
zinc estimated in hair represents the quantity of zinc 
available during the time of hair growth. Urinary zinc 
could be used as a biomarker for predicting zinc 
status, but it has many drawbacks as zinc levels can 
only be estimated if there is acute zinc depletion. 
Apart from this, protein catabolism, starvation, 
strenuous exercise, diabetes, and trauma will result in 
elevated levels of zinc excretion. The use of nails to 
quantify zinc concentrations is limited as there is a 
lack of sensitive equipment to measure nail zinc 
concentration. More than 300 enzymes possess zinc as 
a cofactor for their function. So these bound zinc 
proteins may be secreted or leaked into the 
surrounding circulation. These proteins might act as 
biomarkers reflecting the status of zinc. 
Metallothionein is one of the markers which can serve 
as biomarker as it expression is highly modulated by a 
transcription factor know as MTF-1, which in turn is 
regulated by cellular zinc concentration [17]. 
Metallothionein levels increase with increasing 
cellular zinc concentration and might reflect zinc 
status, but using metallothionein as a biomarker has 
some issues, because it has been reported that there is 
a negative correlation plasma zinc status and 
metallothionein expression in blood mononuclear cell. 
This indicates that stress or inflammation raises the 
metallothionein concentration with concurrent 
depletion of plasma zinc levels thereby complicating 
the use of metallothionein expression has a biomarker 
of zinc levels [18,24] . Alterations in cellular zinc 
status affect the exporting and importing of zinc. It 
has been observed the zinc deficiency causes 
decreased expression of zinc efflux transporters (ZnT1 
or ZnT2). In a human trial of severe zinc deficiency (< 
2 mg dietary zinc/d), the expression of ZnT1 was 
found to be significantly downregulated after ten days 
in the blood cells [19,20]. But it is not clear if the mild 
to moderate deficiency of zinc affects the ZnT1 
expression. A cytoskeletal protein named dematin has 
been recognized as a marker of zinc status during a 
clinical trial of acute zinc deficiency, but it needs 
validation before it can used as a biomarker [20]. 
Oxidative stress generates reactive oxygen species, 
which causes many diseases and zinc has been termed 
as pro-antioxidant as zinc indirectly stimulates the 
cellular antioxidant machinery. Zinc deficiency and 
zinc overload can cause oxidative stress and 
production of free radicals [21].This warrants further 
studies to identify markers of oxidative stress and 
inflammation during mild to moderate zinc deficiency 
with caution as many other factors alter the redox 
state and might give false positives during zinc 
deficient conditions. Zinc deficiency also has been 
shown to affect eicosanoid production in rodents. Zinc 
deficient rat had higher plasma concentrations of 
PGF2α and PGE2 compared to control rats which were 
fed with adequate zinc [22]. It has been suggested the 
ratio of linoleic acid and dihomo--linoleic acid could 
be a potential marker to assess zinc status as 
deficiency affects the conversion of linoleic acid to 
dihomo--linoleic acid [23]. Zinc insufficiency 
impacts innate and adaptive immunity thereby 
influencing host defence and immune response in 
particular. Zinc depletion causes impaired immune 
cell development, compromised T-cell mediated 
immune reaction and elevated oxidative burst. Zinc 
supplementation can mitigate all these, which 
suggests that zinc has anti-inflammatory and 
immunomodulatory function. Zinc consumption 
levels, serum or plasma levels of zinc, and below 
average growth are being used as a yardstick for zinc 
evaluation in population [14] (Janet et al 2016). The 
measurement of zinc nutritional levels by laboratory 
methods is burdensome due to sweeping dispensation 
of zinc all through the body as an integral component 
of numerous proteins and nucleic acids. Plasma zinc 
concentration (PZC) are used recurrently as a 
directory assessing zinc shortage, but one strong 
drawback of PZCs is that they do not represent zinc 
cellular levels for the most part due to rigorous 
homeostatic regulatory mechanisms[16]. However, 
considerable research is required before those 
biomarkers can be used to evaluate the zinc status of 
individuals or populations. There are, at present, no 
preventive zinc programmatic activities at the national 
or international levels. The WHO has not established 
guidelines for large-scale zinc interventions that are 
designed to prevent inadequate zinc nutrition. 
Furthermore, without a sensitive, specific zinc 
biomarker, program planners struggle to assess the 
need for preventive zinc interventions and how to 
measure their impact. 
Identification of zinc deficiency is a tough task. There 
are no dependable biomarkers of zinc status to judge 
health risk. Without an unambiguous and responsible 
biomarker to evaluate the zinc nutritional status, zinc 
intervention program is a struggle. Sensitive and 
precise analysis of zinc status is hence cardinal to 
defining optimal zinc status and setting evidence-
based reference intake level. Presently, the 
biochemical marker for measuring the zinc status is 
quantifying the plasma zinc. Due to the paucity of 
information, active indicators like enzymes and 
proteins which are modulated by zinc levels cannot be 
used to quantify zinc status both in clinical or field 
studies. However, zinc homeostasis depends on many 
factors complicating the detection of marginal zinc 
deficiency. The emerging omics technology could be 
put good use in identifying a reliable marker which 
will become a fruitful aid to diagnose zinc inadequacy 
in populations. 
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CONCLUSION: 
Development of evidence-based clinical guidance and 
effective programs for achieving global health 
promotion depends on the availability of valid and 
reliable biomarker. Zinc deficiency is highly prevalent 
in the human population in under developed or 
developing countries and, at the same time sensitive 
analytical techniques are not yet available to assess 
zinc status in humans. Delicate and specific analysis 
of zinc status is cardinal to delineating optimal zinc 
status. Zinc deficiency causes sweeping changes in 
metabolism affecting many proteins, lipids, and 
microRNAs. The question is could these specific 
proteins, lipids or miRNAs be identified and serve as 
sensitive biomarkers to assess during acute, mild to 
moderate and chronic zinc deficiency.  
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